@0xPolygon is supporting gTrade's growth with a $250k grant targeted for leveraged trading incentives.
🚀 First $150k trading contest is starting January 7th 0:00 UTC and will reward 1,000 traders!
🔎 Details: https://t.co/NIUf244tjh
$MATIC #Polygon#PolygonNetwork
🎁🚨GIVEAWAY🚨🎁
Boo morning everyone!
Here we go again more Free Spirits!
1 winner this time around!
Minting on Polygon 1st Quarter of 2022
To Enter:
1️⃣Like+Follow @FreeSpiritsNFT
2️⃣Retweet
3️⃣Tag 3 friends!
Let's do it Spirits! 🙏♥️♥️
#NFT#NFTGiveaway
We pay our debts that’s why I’m raising the debt limit cos we ran out of available debt due to not paying back the debt we currently have so we can have more and definitely pay it off later btw just not right now
1/4 🎙 The countdown to “polygon zk day" has officially started!
🤩 Join @VitalikButerin along with other leading lights of the Zero-Knowledge space for a discussion about the future of SNARKs, STARKs & applications of ZK proofs.
➡️ Register Now: https://t.co/eQxFL69MkP
I do understand the difference between optimistic rollups, zkRollups, POS side chains, and general EVM vs specific applications, but would be nice to have a review of why someone would choose one optimistic rollup over another or one zk rollup over another. @bankless
2/2
Would love to see a fast chart comparison and a detailed breakdown of the various Ethereum scaling solutions. Arbitrum, Optimism, Polygon Ecosystem (Hermez, Miden, etc), zkSync, Loopring, Starkware, and any others.
Does anyone already have this? 🙏
@bankless
1/2
Dear @Uniswap community,
We submitted a proposal to deploy Uniswap V3 to @0xPolygon. 😊
We firmly believe this is the right moment for this deployment to happen, for reasons explained in the proposal.
Looking forward to your questions and feedback. 🙏
https://t.co/oz84LVdUWj
Is Polygon becoming an index for upside exposure to all the various Ethereum scalability methods?
✅PoS Sidchains
✅Rollup privacy chains
✅zk rollup EVM chains
Cause if so...🚀🚀🚀
We’re excited to announce @UsonaInstitute as our roadmap charity donation recipient. Usona is a non-profit organization dedicated to research into the therapeutic effects of psychedelic medicines with a focus on alleviating treatment-resistant depression.
https://t.co/TqS2JnWK17